SPECTROSCOPIC DETECTION OF FIBROUS CAP THICKNESS OVERLYING LIPID CORE CORONARY PLAQUES WITH A CATHETER-BASED NEAR-INFRARED SPECTROSCOPY SYSTEM  by Madden, Sean et al.
ACC-i2 with TCT
E308
JACC March 27, 2012
Volume 59, Issue 13
SPECTROSCOPIC DETECTION OF FIBROUS CAP THICKNESS OVERLYING LIPID CORE CORONARY 
PLAQUES WITH A CATHETER-BASED NEAR-INFRARED SPECTROSCOPY SYSTEM
i2 Oral Contributions
McCormick Place South, S106b
Sunday, March 25, 2012, 9:00 a.m.-9:10 a.m.
Session Title: Intravascular Diagnostics
Abstract Category: 3. Intravascular Diagnostics
Presentation Number: 2508-13
Authors: Sean Madden, Joel Raichlen, James Muller, Infraredx, Inc., Burlington, MA, USA
Background: Intravascular near-infrared spectroscopy (NIRS) is robust and well-validated for detection of coronary lipid core plaque (LCP). NIRS 
LCP detection is based on differing NIR signatures of cholesterol and collagen, which can also potentially differentiate LCP cap thickness by the 
amount of collagen signal contribution. This study assessed agreement between a NIRS system determination of LCP cap thickness and histology in 
coronary artery autopsy specimens and tested the algorithm in selected clinical studies.
Methods: NIRS was performed through blood in 212 coronary segments from 84 autopsy hearts. Histologic sections were analyzed every 2mm, 
and minimum fibrous cap thickness in each LCP section was measured. A cross-validation scheme was used to evaluate the accuracy of NIRS in 
characterizing fibrous caps as thin (<65 μm).
Results: Thin regions were present in 70 of 901 (7.8%) sections. The algorithm classified fibrous cap thickness with an AUC of 0.76 (95% CI: 0.71 
to 0.81). A retrospective analysis of fibrous cap thickness conducted in clinical NIRS displays containing LCPs, confirmed the applicability of the 
technique to in vivo images.
Conclusions: This novel catheter-based NIRS system already in clinical use to identify LCPs in patients, accurately identified fibrous cap thickness 
overlying LCP through blood in coronary autopsy specimens. This capability may be of value in the management of patients with coronary artery 
disease and in the development of anti-atherosclerotic drugs.
 
